-
1
-
-
58149186453
-
Adjuvant external beam RT in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): Pooled trial results, systematic review, and meta-analysis
-
P. Blake, A.M. Swart, and J. Orton Adjuvant external beam RT in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): Pooled trial results, systematic review, and meta-analysis Lancet 373 2009 137 146
-
(2009)
Lancet
, vol.373
, pp. 137-146
-
-
Blake, P.1
Swart, A.M.2
Orton, J.3
-
2
-
-
84869016236
-
Adjuvant radiotherapy for stage i endometrial cancer: An updated Cochrane systematic review and meta-analysis
-
A. Kong, N. Johnson, and H.C. Kitchener Adjuvant radiotherapy for stage I endometrial cancer: An updated Cochrane systematic review and meta-analysis J Natl Cancer Inst 104;21 2012 1625 1634
-
(2012)
J Natl Cancer Inst
, vol.104
, Issue.21
, pp. 1625-1634
-
-
Kong, A.1
Johnson, N.2
Kitchener, H.C.3
-
3
-
-
0344626922
-
Survival after relapse in patients with endometrial cancer: Results from a randomized trial
-
C.L. Creutzberg, W.L.J. van Putten, and P.C. Koper Survival after relapse in patients with endometrial cancer: results from a randomized trial Gynecol Oncol 89 2003 201 209
-
(2003)
Gynecol Oncol
, vol.89
, pp. 201-209
-
-
Creutzberg, C.L.1
Van Putten, W.L.J.2
Koper, P.C.3
-
4
-
-
84891608485
-
Long-term outcomes after pelvic radiation for early-stage endometrial cancer
-
M. Onsrud, M. Cvancarova, and T.P. Hellebust Long-term outcomes after pelvic radiation for early-stage endometrial cancer J Clin Oncol 31 2013 3951 3956
-
(2013)
J Clin Oncol
, vol.31
, pp. 3951-3956
-
-
Onsrud, M.1
Cvancarova, M.2
Hellebust, T.P.3
-
5
-
-
77649130174
-
Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial carcinoma of high-intermediate risk (PORTEC-2): An open-label, non-inferiority, randomised trial
-
R.A. Nout, V.T. Smit, and H. Putter Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial carcinoma of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial Lancet 375 2010 816 823
-
(2010)
Lancet
, vol.375
, pp. 816-823
-
-
Nout, R.A.1
Smit, V.T.2
Putter, H.3
-
6
-
-
84862758072
-
Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data
-
R.A. Nout, H. Putter, and I.M. Jurgenliemk-Schulz Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data Eur J Cancer 48 2012 1638 1648
-
(2012)
Eur J Cancer
, vol.48
, pp. 1638-1648
-
-
Nout, R.A.1
Putter, H.2
Jurgenliemk-Schulz, I.M.3
-
7
-
-
84864413479
-
Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/ss-catenin and P53 pathway activation
-
R.A. Nout, T. Bosse, and C.L. Creutzberg Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/ss-catenin and P53 pathway activation Gynecol Oncol 126 2012 66 73
-
(2012)
Gynecol Oncol
, vol.126
, pp. 66-73
-
-
Nout, R.A.1
Bosse, T.2
Creutzberg, C.L.3
-
8
-
-
84881657484
-
L1CAM in early-stage type i endometrial cancer: Results of a large multicenter evaluation
-
A.G. Zeimet, D. Reimer, and M. Huszar L1CAM in early-stage type I endometrial cancer: Results of a large multicenter evaluation J Natl Cancer Inst 105 2013 1142 1150
-
(2013)
J Natl Cancer Inst
, vol.105
, pp. 1142-1150
-
-
Zeimet, A.G.1
Reimer, D.2
Huszar, M.3
-
9
-
-
51449124307
-
Clinician and cancer patient views on patient participation in treatment decision-making: A quantitative and qualitative exploration
-
A.H. Pieterse, M.C. Baas-Thijssen, and C.A. Marijnen Clinician and cancer patient views on patient participation in treatment decision-making: A quantitative and qualitative exploration Br J Cancer 99 2008 875 882
-
(2008)
Br J Cancer
, vol.99
, pp. 875-882
-
-
Pieterse, A.H.1
Baas-Thijssen, M.C.2
Marijnen, C.A.3
-
10
-
-
84906097680
-
Treatment preferences and involvement in treatment decision making of patients with endometrial cancer and clinicians
-
M. Kunneman, A.H. Pieterse, and A.M. Stiggelbout Treatment preferences and involvement in treatment decision making of patients with endometrial cancer and clinicians Br J Cancer 111 2014 673 679
-
(2014)
Br J Cancer
, vol.111
, pp. 673-679
-
-
Kunneman, M.1
Pieterse, A.H.2
Stiggelbout, A.M.3
-
11
-
-
75749089548
-
A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: Toward improving individualized cancer care
-
N.R. Abu-Rustum, Q. Zhou, and J.D. Gomez A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: Toward improving individualized cancer care Gynecol Oncol 116 2010 399 403
-
(2010)
Gynecol Oncol
, vol.116
, pp. 399-403
-
-
Abu-Rustum, N.R.1
Zhou, Q.2
Gomez, J.D.3
-
12
-
-
84861194586
-
Nomograms to predict isolated loco-regional or distant recurrence among women with uterine cancer
-
S. Kondalsamy-Chennakesavan, C. Yu, and M.W. Kattan Nomograms to predict isolated loco-regional or distant recurrence among women with uterine cancer Gynecol Oncol 125 2012 520 525
-
(2012)
Gynecol Oncol
, vol.125
, pp. 520-525
-
-
Kondalsamy-Chennakesavan, S.1
Yu, C.2
Kattan, M.W.3
-
13
-
-
84885310363
-
Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer
-
M.M. Alhilli, K.C. Podratz, and S.C. Dowdy Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer Gynecol Oncol 131 2013 103 108
-
(2013)
Gynecol Oncol
, vol.131
, pp. 103-108
-
-
Alhilli, M.M.1
Podratz, K.C.2
Dowdy, S.C.3
-
14
-
-
18144432776
-
Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma
-
C.L. Creutzberg, W.L. van Putten, and P.C. Koper Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma Lancet 355 2000 1404 1411
-
(2000)
Lancet
, vol.355
, pp. 1404-1411
-
-
Creutzberg, C.L.1
Van Putten, W.L.2
Koper, P.C.3
-
15
-
-
80255137489
-
Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma
-
C.L. Creutzberg, R.A. Nout, and M.L. Lybeert Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma Int J Radiat Oncol Biol Phys 81 2011 e631 e638
-
(2011)
Int J Radiat Oncol Biol Phys
, vol.81
, pp. e631-e638
-
-
Creutzberg, C.L.1
Nout, R.A.2
Lybeert, M.L.3
-
16
-
-
2142640269
-
Outcome of high-risk stage IC, grade 3, compared with stage i endometrial carcinoma patients: The Postoperative Radiation Therapy in Endometrial Carcinoma Trial
-
C.L. Creutzberg, W.L. van Putten, and C.C. Warlam-Rodenhuis Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial J Clin Oncol 22 2004 1234 1241
-
(2004)
J Clin Oncol
, vol.22
, pp. 1234-1241
-
-
Creutzberg, C.L.1
Van Putten, W.L.2
Warlam-Rodenhuis, C.C.3
-
17
-
-
84856071733
-
Survival of Danish patients with endometrial cancer in the intermediate-risk group not given postoperative radiotherapy: The Danish Endometrial Cancer Study (DEMCA)
-
K. Bertelsen, G. Ortoft, and E.S. Hansen Survival of Danish patients with endometrial cancer in the intermediate-risk group not given postoperative radiotherapy: The Danish Endometrial Cancer Study (DEMCA) Int J Gynecol Cancer 21 2011 1191 1199
-
(2011)
Int J Gynecol Cancer
, vol.21
, pp. 1191-1199
-
-
Bertelsen, K.1
Ortoft, G.2
Hansen, E.S.3
-
18
-
-
84888259912
-
Omitting adjuvant radiotherapy in endometrial cancer increases the rate of locoregional recurrences but has no effect on long-term survival: The Danish Endometrial Cancer Study
-
G. Ortoft, E.S. Hansen, and K. Bertelsen Omitting adjuvant radiotherapy in endometrial cancer increases the rate of locoregional recurrences but has no effect on long-term survival: The Danish Endometrial Cancer Study Int J Gynecol Cancer 23 2013 1429 1437
-
(2013)
Int J Gynecol Cancer
, vol.23
, pp. 1429-1437
-
-
Ortoft, G.1
Hansen, E.S.2
Bertelsen, K.3
-
19
-
-
58249087699
-
Sensitivity to input variability of the Adjuvant! online breast cancer prognostic model
-
E.M. Ozanne, D. Braithwaite, and K. Sepucha Sensitivity to input variability of the Adjuvant! online breast cancer prognostic model J Clin Oncol 27 2009 214 219
-
(2009)
J Clin Oncol
, vol.27
, pp. 214-219
-
-
Ozanne, E.M.1
Braithwaite, D.2
Sepucha, K.3
-
20
-
-
84858258012
-
Prognostic significance of lymphovascular space invasion and nodal involvement in intermediate- and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy
-
K. Narayan, P. Khaw, and D. Bernshaw Prognostic significance of lymphovascular space invasion and nodal involvement in intermediate- and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy Int J Gynecol Cancer 22 2012 260 266
-
(2012)
Int J Gynecol Cancer
, vol.22
, pp. 260-266
-
-
Narayan, K.1
Khaw, P.2
Bernshaw, D.3
-
21
-
-
13844256730
-
Lymphvascular space involvement: An independent prognostic factor in endometrial cancer
-
J.M. Briet, H. Hollema, and N. Reesink Lymphvascular space involvement: An independent prognostic factor in endometrial cancer Gynecol Oncol 96 2005 799 804
-
(2005)
Gynecol Oncol
, vol.96
, pp. 799-804
-
-
Briet, J.M.1
Hollema, H.2
Reesink, N.3
-
22
-
-
0036921816
-
Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer?
-
D.E. Cohn, N.S. Horowitz, and D.G. Mutch Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer? Gynecol Oncol 87 2002 243 246
-
(2002)
Gynecol Oncol
, vol.87
, pp. 243-246
-
-
Cohn, D.E.1
Horowitz, N.S.2
Mutch, D.G.3
-
23
-
-
84877254190
-
Integrated genomic characterization of endometrial carcinoma
-
C. Kandoth, N. Schultz, and A.D. Cherniack Integrated genomic characterization of endometrial carcinoma Nature 497 2013 67 73
-
(2013)
Nature
, vol.497
, pp. 67-73
-
-
Kandoth, C.1
Schultz, N.2
Cherniack, A.D.3
|